These structural alterations, mediated by the loss of CTCF binding, facilitate direct interactions between MYC promoters and distal super-enhancers, resulting in significant MYC up-regulation and enhanced TAD interactions in T-ALL cells [109]. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.